Levofloxacina Doc

Levofloxacin, the active ingredient in Levofloxacina Doc, is a fluoroquinolone presented as an oral tablet for systemic use. It treats a range of bacterial infections including urinary tract infections, respiratory tract infections, skin and soft‑tissue infections, and prostatitis in adult patients.

GNH USA supplies Levofloxacina Doc as a licensed, GDP‑compliant international pharmaceutical product to hospitals, pharmacies, clinics and procurement teams worldwide, ensuring quality and regulatory compliance.

Levofloxacin is indicated for several bacterial infection categories, acting by eliminating susceptible pathogens. - Urinary tract infection: eradicates causative bacteria and alleviates urinary symptoms. - Respiratory tract infection: treats community‑acquired pneumonia and acute exacerbations of chronic bronchitis. - Skin and soft‑tissue infection: resolves cellulitis, wound infections and related conditions. - Prostatitis: clears bacterial infection of the prostate and reduces associated inflammation.

Levofloxacina Doc may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Tendon rupture: sudden pain or swelling of tendons, especially Achilles. - QT interval prolongation: cardiac rhythm disturbances that may lead to arrhythmia. - Severe allergic reaction: rash, swelling, bronchospasm or anaphylaxis.

When prescribing Levofloxacina Doc, clinicians should consider several safety measures to minimize risk. - Assess renal function: dose adjustment may be required in impaired clearance. - Review cardiac history: avoid in patients with known QT prolongation. - Monitor for tendon symptoms: discontinue if pain, swelling or rupture occurs. - Evaluate for hypersensitivity: discontinue at first sign of severe allergic reaction. - Avoid use in children and pregnant women unless clearly justified: limited safety data are available. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Levofloxacina Doc can affect the pharmacokinetics of other medicines; awareness of key interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption; separate dosing by at least 2 hours. - Warfarin: may increase anticoagulant effect and bleeding risk; close INR monitoring required. - Theophylline: increased plasma levels can cause toxicity; consider dose reduction.

Moderate Interactions (Monitor Closely): - NSAIDs (e.g., ibuprofen): may heighten risk of central nervous system stimulation. - Corticosteroids: combined use may raise tendon rupture risk. - Diabetic agents (e.g., insulin, sulfonylureas): levofloxacin can cause dysglycemia; monitor blood glucose.